Congenital Hyperinsulinism International
Congenital Hyperinsulinism International (CHI) is a nonprofit 501(c)(3) corporation dedicated to improving the lives of babies, children, and adults affected by congenital hyperinsulinism (HI). HI is a life-threatening genetic disorder that causes severe low blood sugar (hypoglycemia) in infants and children, though in 50% of patients, the genetic cause is unknown. For those with HI, the beta cells of the pancreas secrete too much insulin in an unregulated manner. Excess insulin causes hypoglycemia. Prolonged or severe hypoglycemia can cause seizures, permanent brain damage, or even death if left untreated. A good prognosis is far more likely with a timely diagnosis and proper management.
Financial Overview
From 2024 IRS Form 990-PF
Total Assets
$2.2M
+20.6% YoY
Annual Giving
$67K
+110.8% YoY
Grant Count
1
+0.0% YoY
Avg Grant Size
$67K
+110.8% YoY
Go deeper than public filings
PRO- Giving trend analysis — growing or declining?
- Organizations like yours that won grants here
- Strategic fit assessment for your organization
- Application timing recommendations
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $2,173,955 | $1,803,323 | $1,644,315 |
| Revenue | $1,275,774 | $1,150,291 | $1,262,625 |
| Expenses | $1,126,855 | $1,043,446 | $834,055 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $63,858 | $25,235 | — |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 1 recipients in 2024
Grant Size Distribution
6 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Who else does Congenital Hyperinsulinism International fund?
Explore the funder–grantee relationships behind this foundation, powered by GrantGraph™ — our database of 11 million+ funding connections.
- Similar orgs that won grants here
- GrantGraph™ relationship mapping
- 11M+ connections in GrantGraph™
Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| JULIE RASKIN | CEO | 40 | $114,071 |
| TAI PASQUINI | CRO | 40 | $95,000 |
| JENNIFER SCHMITT | COO | 40 | $90,000 |
| SHEILA BOSE | Secretary | 6 | — |
| LAURA SULLIVAN | President | 6 | — |
| JULIE SHELDON | Vice President | 1 | — |
| MASON SMITH | Treasurer | 2 | — |
| JUSTYNA MONTEMURRO | Director | 1 | — |
| PAM WILLIAMS | Director | 1 | — |
| TRUDY WARD | Director | 1 | — |
Geographic Focus
Where this funder has awarded grants
Grant Distribution by State
States
Cities
Data last updated March 2026. Sourced from IRS Form 990-PF filings.
What could you do with Congenital Hyperinsulinism International on Grantable?
- Assess strategic fit with your organization
- Get AI-generated opportunity briefs
- Monitor for new funding opportunities
- Draft a tailored letter of inquiry